Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > HUGE PRICE TARGET
View:
Post by Akia1818 on Mar 10, 2021 12:03am

HUGE PRICE TARGET

According to 2 Wall Street analysts that have issued a 1 year HUGE price target, the average HUGE price target is $10.85, with the highest HUGE stock price forecast at $11.70 and the lowest HUGE stock price forecast at $10.00.

On average, Wall Street analysts predict that FSD Pharma's share price could stay at $10.85 by Nov 13, 2021. The average FSD Pharma stock price prediction forecasts a potential downside of N/A from the current HUGE share price of $1.74.
Comment by Akia1818 on Mar 10, 2021 12:05am
The consensus among 1 Wall Street analysts covering (NASDAQ: HUGE) stock is to Strong Buy HUGE stock. Out of 1 analysts, 1 (100%) are recommending HUGE as a Strong Buy, 0 (0%) are recommending HUGE as a Buy, 0 (0%) are recommending HUGE as a Hold, 0 (0%) are recommending HUGE  ...more  
Comment by Chuckie18 on Mar 10, 2021 12:12am
I get the feeling that PED will eventually be more than something that is just keeping the lights on. The new facility seems like it could put the company in a really good position moving forward.
Comment by NLMoose on Mar 10, 2021 6:55am
With the courts finally cracking down on Dr. Bokhari and FSD Pharma Executive, we could see the courts and securities commissions strip them of any stocks they received in January, making HUGE stock attractive to buy.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities